FRACTYL HEALTH, INC. Research And Development Expense

Quick Answer

FRACTYL HEALTH, INC. reported Research And Development Expense of $74.54 million for the year ending 2025.

  • FRACTYL HEALTH, INC. showed an increase of +5.8% in Research And Development Expense from 2024 to 2025.
  • This data is from FRACTYL HEALTH, INC.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), FRACTYL HEALTH, INC.'s Research And Development Expense has grown by 96.0%.
  • Historical annual values: Fiscal year 2025: $74.54 million | Fiscal year 2024: $70.47 million | Fiscal year 2023: $38.04 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: